FFCP PHASE2:Hg19::chr1:226865172..226865191,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chr1:226865172..226865191, + |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr1:226865172..226865191, + |
| Coexpression cluster: | C6_CD14_Eosinophils_Basophils_Peripheral_CD34_Natural_immature |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr1:226865172..226865191+ |
|---|
0.0
2.5
5.0
7.5
10.0
12.5
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| granulocyte | 2.47e-39 | 8 |
| leukocyte | 5.45e-35 | 136 |
| blood cell | 2.10e-28 | 11 |
| hematopoietic stem cell | 2.04e-27 | 168 |
| hematopoietic oligopotent progenitor cell | 1.60e-26 | 161 |
| hematopoietic multipotent progenitor cell | 1.60e-26 | 161 |
| intermediate monocyte | 4.24e-26 | 9 |
| CD14-positive, CD16-positive monocyte | 4.24e-26 | 9 |
| hematopoietic cell | 8.91e-26 | 177 |
| myeloid leukocyte | 2.60e-25 | 72 |
Showing 1 to 10 of 47 entries
| Ontology term | p-value | n |
|---|---|---|
| hematopoietic system | 4.58e-10 | 98 |
| blood island | 4.58e-10 | 98 |
| connective tissue | 1.29e-09 | 371 |
| hemolymphoid system | 6.79e-09 | 108 |
| bone marrow | 2.95e-08 | 76 |
| bone element | 1.61e-07 | 82 |
Showing 1 to 6 of 6 entries
